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Abstract The objective of this study was to determine the contrlbutlon of renal nerves to the enhanced afferent arterlolar reactivity observed m anglotensm II (Ang II)-induced hypertension Unmephrectomlzed Sprague-Dawley rat3 were divided mto four groups sham rats, renal-denervated rats, Ang II-Infused (at 40 nglmm for 13 days) rats, and Ang II-mfused+renal-denervated rats With the use of an Implanted arterial catheter, mean arterial pressure (MAP) was momtored m conscious rats Ang II Infusion resulted m a progressive increase In MAP from 982 I (day 0) to 16627 mm Hg (day 13) This Increase In MAP was attenuated tn denervated rats and averaged 136?3 mm Hg on day 13 Kidneys were harvested on day 13 for mlcloclrculatory expenments or measurement of mtrarenal Ang II levels Basal afferent arterlolar diameter was similar in all groups, and group averages ranged from 19 6 to 20 7 pm Chrome Ang II Infusion increased mtrarenal Ang II levels Renal denervatlon did not alter this effect Increasing perfusion pressure from 100 to 160 mm Hg reduced afferent artermlar diameter slgnlficantly by I I 250 6% m the sham group and by a similar degree m the remaining three groups Superfusion with Ang II (10 nmol/L) reduced afferent arterlolar diameter by 34 3+2 0% m the sham group This response was enhanced m Ang II-Infused (62 353 4%) but not in renal-denervated or Ang II-mfused+renal-denervated rats Addmonally, the enhanced afferent arteriolar reactivity to Ang II wa$ not Influenced by adrenerglc receptor blockade The afferent artenolar response to noreplnephrme wa? enhanced m renal-denervated, Ang II-infused, and Ang II-mtused+renal-denervated rats compared with sham controls Admmlstratlon of the calcium lonophore A23187 decreased afferent arterlolal diameter slmllarly m all four groups These results indicate that renal nerves contribute to the development of hypertension and to the enhanced afferent artellolar responsiveness to Ang II ehclted by chronic Ang II mfu\lon (Hypertenwn. 1997 Measurement of Blood Pressure and Heart Rate SAP was measured every 3 days m conscious rats by tall-cuff plethysmography (model 52-0338, Harvard Apparatus) Direct determmations of MAP and heart rate were made m SIX rats from each group by lmplantahon of an mdwelhng catheter The catheter (PE-10) was placed m the abdominal aorta via the left femoral artery The distal end was Joined to PE-50 tubing and passed subcutaneously to the dorsum of the neck Patency was mamtamed with a heparm lock MAP and heart rate measurements were made with a blood pressure analyzer (model BPAlOOE, Micro Med, Inc) Assessment of Afferent Arteriolar Reactivity Afferent arterlolar reactivity was assessed with the m vitro blood-perfusedJuxtamedullary nephron technique combined with vldeon-ucroscopy, as previously described 15 16 Expenments were performed on day 13 after mmlpump lmplantatlon Each experiment used two rats from the same treatment group (ie, SH, DX, ANG, or ANG+DX), with one rat serving as the blood donor and the second rat as the kidney donor Rats were anesthetized with so&urn pentobarbitaI(50 mg/kg IP) The nght kidney of the blood donor was harvested for measurements of renal Ang II and norepmephrme contents Blood was collected mto a heparmized (500 U) syringe via a carotid arterial cannula Plasma and erythrocyte fractions were collected and prepared as previously described 15,16 Reconstituted blood was passed through a S-pm nylon mesh and oxygenated m a closed reservoir with a 95% 02/ 5% CO* gas mixture
The right kidney of the kidney donor was cannulated and perfused with a Tyrode's solution (pH 7 4) containing 5 1% bovine serum albumin and a mixture of L-ammo acids (Sigma Chemical Co) The kidney was excised and sectioned longitu&ally, with the papilla retained intact m the perfused dorsal two thirds of the organ The papilla was reflected back, and the tissue covering the mner cortical surface was removed Large arteries not supplying the tissue being studied were ligated, and the inner cortical surface was contmuously superfused with a warmed (37°C) Tyrode's solution containing 1% bovine serum albumin The Tyrode's perfusate was replaced with the reconstituted blood Perfusion pressure was monitored at the peifuSian cannula tip, and renal perfusion pressure wa\ mitially set at 100 mm Hg
The tissue was translllummated on the fixed stage of a Nikon Xenophot microscope equipped with long-working-distance obJectlves Video images obtained by a Newvicon camera (model NC-67M, Dage-MTI) were electronically enhanced (MFJ-1452, MFJ Enterprises), displayed on a monitor (Conrac Display Systems), and recorded on videotape fol later analysis (Super VHS Videocassette recorder, Panasonic) Afferent arterlolar inside chameter was measured with an image-shearing monitor (Instrumentation for Physiology & Medicine) Lahbrated with a stage micrometer Lummal diameter was measured at 12-second mtervals, and the steady-state diameter wa3 averaged over the final 2 minutes of each 5-minute treatment period Experimental Protocols A lo-minute eqmhbratlon period wds allowed before the mltiation of each assessment of afferent arteriolar reactivity Autoregulatory capability was assessed by increasing renal perfusion pressure m a stepwise manner from 100 to 130 and 160 mm Hg 16 The effect of Ang II on atferent arteriolar diameter was examined by exposing the tissue to 0 1 and 10 nmol/L Ang II The effect of norepmephrme (Levophed bitartrate, Sanofi Winthrop Pharmaceutlcals) on afferent arterlolar diameter was examined by superfusing the tissue with 10 nmol/L and 1 bmoI/L norepmephrme The effect of the calcium lonophore A23187 on afferent arteriolar diameter was also determined After the control period, the tissue was exposed by admmistration of l-and lOO-nmoliL concentrations of A23 187
To control for the possiblhty that acute superfusion with Ang II might stimulate neurotransmltter release from sympathetic varlcoslties m kidneys from nerve-intact SH and ANG rats, we also performed experiments during adrenerglc receptor blockade Accorclmg to the procedures described above, afferent arterlolar dlameter responses to Ang II were assessed before and during superfusion with a combmatlon of adrenerglc receptor antagonist?
(1 pmol/L prazosm, 10 pmol/L propranolol, and 10 pmol/L yohimbme, Sigma) This combmatlon of adrenerglc receptor antagomsts completely mhiblted the afferent arterlolar vasoconstriction ehclted by 1 bmol/L norepmephrme In the presence of the adrenergic receptor antagonists, 1 pmol/L norepmephrme decreased afferent arterlolar diameter by 0 2+-O 5% compared with control vasoconstriction of 61 S-CO 6% Time control expenments (n=4) performed to determine the reproduciblhty of dfferent artertolar responses to repeat Ang II admuustration revealed no significant difference m the responses between the first and second treatments Ang II concentrations of 0 1 and 10 nmol/L decreased affelent arterlolar dlametel by 32 5" I 7% and 34 222 3%, respectively, m the SH group and by 52 7i-I 6% and 53 8+ 14% m the ANG group
Measurement of Renal Ang II and Norepinephrine Contents
Kidneys collected for measurement of mtrarenal Ang II and norepmephnne contents were quickly decapsulated and weighed As previously described, 17.17 kidneys used for the analysis of mtrarenal Ang II were placed m ice-cold methanol (10% wtlvol), homogenized with a chilled glass homogenizer, and centrifuged The supernatants wete dried and reconstituted m 4 mL of 50 mmol/L so&urn phosphate buffer containing 1% albumin Reconstituted samples were extracted (Bond-Elut, Analytichem), and the eluates were evaporated to dryness and reconstituted m Ang II assay diluent Ang II content was measured by radlmmmunoassay using rabbit anti-Ang II antisera (Arnel) as previously reported '?I' The sensitivity of the Ang II assays was 1 5?0 3 fmoI/g during 90% maximal bmdmg Specific bmdmg was 36 5?2 8%, and nonspecific bmdmg was 0 920 1% for the Ang II assays
The remaining kidneys were used for measurement of mtrarenal norepmephrme content Each kidney was rapidly frozen m 1 mL of 0 1 mol/L perchloric acid and stored at -70°C until analyzed The frozen samples were homogenized m 10 mL icecold 0 3 mol/L perchlorlc acid and centrifuged at 20 OOOg fol 20 minutes at 4°C Norepmephrme content m the supernatant of the renal homogenate was determined by high-performance hquld chromatography coupled with an electrochemical detector (model LC-44, Bloanalytical Systems), using a Microsorb Cl 8 column (4 6x150 mm) (Ramm Instruments) and a Pelkm-Elmer series 10 HPLC pump The retention times for norepmephrme averaged 5 2 minutes Statistical Analysis Between-and wltlun-group analyses were performed with unpaired and paned t tests, respectively Two-way ANOVA with repeated measures on one factor and Fisher's protected leastsquares difference test were also used for determmation of &f-ferences between groups for measurements of MAP, SAP, and afferent artenolar diameter A value of P-C 05 was considered significant Data are presented as mea&SE
Results
Effect of Renal Denervation on Arterial Pressure in Ang II-Infused Rats As illustrated m Fig lA, MAP averaged lOO?l and 9821 mm Hg in SH and DX rats, respectively, and it remained at these levels throughout the 13-day infusion penod Chronic Ang II mfuslon m ANG rats led to progressive increases in MAP from a basal level of 98?1 to 16627 mm Hg by day 13. In ANG+DX rats, the increase m MAP durmg chronic Ang II infusion was attenuated and averaged 136+3 mm Hg on day 13, but MAP was still slgmficantly greater than the starting MAP of SH rats after 13 days of vehicle infusion. Heart rate averaged 42125, 419+-8,426?5, and 41828 beats per minute m SH, DX, ANG, and ANG+DX rats (n=6 m each group), respectively, on day 0 and did not change m any group during the 13 days of study On day 13, body weights averaged 312+2 and 317%4 g for the SH (n= 15) and DX (n= 15) rats, respectively, and 297+-4 and 29923 g for the ANG (n=19) We assessed mtrarenal Ang II levels to determine whether renal denervatlon altered mtrarenal Ang II content Intrarenal Ang II contents did not differ between the SH (153239 fmol/g, n=6) and DX (163222 fmol/g, n=6) groups Ang II infusion for 13 days increased (P<.O5) mtrarenal Ang II content similarly m the ANG (307220 fmol/g, n=7) and ANG+DX (287226 fmol/g, n=7) groups Thus, although mtrarenal Ang II content was sigmficantly increased by chronic Ang II infusion as prevlously reported,'.3 renal denervation did not modify this increase.
Intrarenal norepmephrme levels averaged 135 +_ 12 and 129?6 rig/g tissue in the SH (n=5) and ANG (n=5) groups, respectively. These values were greater than those m kidneys from the DX (3324 rig/g, n=5) and ANG+DX (37+4 rig/g, n=5) groups and demonstrate the effectlveness of the denervation procedure Nevertheless, mtrarenal We performed in vitro expenments using the Juxtamedullary nephron preparation to assess afferent artenolar reactivity At a perfusion pressure of 100 mm Hg, afferent arterlolar diameters were similar m all four groups and averaged 199209 (SH), 20 1207 (DX), 195t07 (ANG), and 20.720.6 (ANG+DX) pm. The site along the afferent arteriole where lummal diameters were measured averaged between 78 and 83 pm from the glomerulus for each of the four groups Fig 2 illustrates the effects on afferent arterlolar dlameter of increasing perfusion pressure In kidneys from SH rats, increasing perfusion pressure from 100 to 130 and 160 mm Hg slgmficantly reduced afferent arterlolar diameter from 19.9t0.9 to 18 8+-l 0 and 17.720 9 pm, respectively. Similar results were obtained m the other three groups (Fig 2A) 
Effects of Chronic Ang II Infusion and Renal Denervation on the Responsiveness of Afferent Arterioles to Ang II
Baselme afferent arteriolar diameters were similar m each group and averaged 19 851 1,20 220 7, 19 1-I-O 9, and 20 620 6 pm m the SH, DX, ANG, and ANG+DX groups, respectively (Ftg 3A) Superfusion wtth Ang II sigmficantly decreased afferent arteriolar diameter in all four rat groups (Fig 3A, P< .05 versus respective control diameter), however, afferent arteriolar responsiveness to Ang II was significantly enhanced m the ANG group ( Fig  3B) Interestmgly, renal denervation (ANG+DX) completely prevented the enhanced reactivity to Ang II ehcited by chrome Ang II infusion Afferent arteriolar responsiveness to Ang II superfusion in the ANG+DX rats was not srgmficantly different from that m the SH or DX control rats Denervatton alone did not attenuate the afferent arteriolar responses compared with those observed m SH rats.
Effects of Chronic Ang II Infusion and Renal Denervation on the Responsiveness of Afferent Arterioles to Norepinephrine
As shown m Fig 4A, norepmephrme significantly reduced afferent arteriolar inside diameter from 19 3 2 1.3 to 11 7* 1 0 pm m the SH groups. Chrome renal denervation significantly enhanced the responsiveness of afferent arterioles to norepmephrme, mdmatmg denervation hypersensitivity Superfuston of norepmephrme (1 pmol/L) sigmficantly decreased afferent arteriolar diameter from 20 2tO 8 to 7 120 4 pm m DX rats. Chronic Ang II infusion also enhanced the afferent arteriolar vasoconstrictor responses to norepmephrme Norepmephrme (1 PmollL) significantly reduced afferent artertolar diameter from 19.4&O 9 to 6 8eO.4 pm m ANG rats The magnitude of this response was stgmficantly greater than that observed m SH rats (Fig 4B, P< 05 ) This enhanced response to norepmephrme m the Ang II-infused rats was not altered by chrome renal denervation since the response m the ANG+DX group was similar to that observed m the ANG group (20 5~0 7 to 6.7+-O 3 pm) Thus, no stgmficant differences m norepmephrme-evoked afferent artenolar vasoconstriction were observed among the DX, ANG, and ANG+DX groups (Fig 5A) The magnitudes of the responses to A23 187 were stmtlar m all four rat groups (Fig 5B) The afferent artertolar response to A23 187 was unaffected by renal denervatton, chronic Ang II mfusion, or the combmatton of renal denervatton and chronic Ang II mfusion
Effects of Adrenergic Receptor Blockers on the Enhanced Responsiveness of Afferent Arterioles to Ang II
The effect of adrenergtc receptor blockade on the afferent artenolar vasoconstrtctor response to Ang II is dlustrated m Ftg 6 Adrenergx receptor blockers did not affect basal afferent arteriolar diameter m any of the groups Durmg adrenergtc receptor blockade, afferent diameter decreased by 35 523 0% m response to 10 nmol/L Ang II m SH rats This decrease was stmilar to that (34 6-t-2 9%) observed before adrenergtc receptor blockade (Fig 6A) In ktdneys from ANG rats, Ang 11 (10 nmol/L) srgmficantly reduced afferent arteriolar inside diameter by 56 422 5% before adrenergic blockade This decrease was greater than that observed m SH rats (P< 05) but was not altered by adrenergic receptor blockade (57 4+2 9%) Thus, adrenergtc receptor blockade dtd not alter basal afferent artertolar diameter or the diameter response to Ang II m SH or ANG rats Discussion Both dtrect and mdirect measurements of arterial pressure confirmed previous reports that chronic mfusions of mtttally subpressor doses of Ang II lead to a slowly developing hypertension ~9~2 Renal denervation attenuated the increase m MAP m our model In both groups, arterial pressure increased without sigmficantly changing heart rate This is consistent with previous studies m rabbits m which Ang II infusion has been shown to reset the baroreceptors to mamtam a higher arterial pressure without adlustmg heart rate 1~~" Since resettmg of the baroreceptors is mediated via central a,-adrenergic receptors,*' limiting the denervation to include only the renal nerves does not influence resetting of the baroreceptors during chronic Ang II mfuston
In the present study, afferent arteriolar responsiveness to increasing perfusion pressure was not significantly altered by chronic Ang II mfuston m either innervated or denervated rats In contrast, afferent artertolar responsiveness to Ang II and norepmephrme was enhanced m rats chronically infused with Ang II compared with SH rats The enhanced reactivity to Ang II was prevented by renal denervation, suggesting that enhanced afferent arteriolar reactivity to Ang II requires intact renal nerves Several possible explanations could be considered for renal nerve mvolvement m the enhanced afferent artertolar responsiveness to Ang II First, since Ang II is known to facihtate sympathetic neurotransmtssion,25.26 acutely admnnstered Ang II might stimulate neurotransmitter release from intact sympathettc nerve varicosmes m the microvasculature of kidneys harvested from ANG rats This acute, Ang II-mediated neurotransmitter release could enhance the afferent artenolar vasoconstrictton through an adrenoceptor-mediated mechanism However, since afferent artenolar reactivity to Ang II was not affected by adrenergic receptor blockade m kidneys from ANG rats, this explanation seems unlikely unless Ang II is stlmulatmg release of a nonadrenergic neurotransmltter Second, although renal denervatton does not affect the mtrarenal angtotensmogen mRNA levels m rats,27 renal nerves might contribute to the mtrarenal accumulation of Ang II during chronic Ang II infusions and enhance the afferent artenolar responsiveness to acutely administered Ang II However, the elevated mtrarenal Ang II content in ANG+DX rats did not differ from that observed m ANG rats Another possibihty is that chronic Ang II mfuslon mtght contmuously modulate sympathetic neurotransmtssion by directly enhancing renal nerve activity or by enhanced stimulatton of the central nervous system sympathetic activity This chronically modulated neurotransmission might alter the responsiveness of afferent arteriolar smooth muscle cells to Ang II. Anally, it may be that the ability of renal denervation to prevent enhancement of afferent at teriolar responsiveness to Ang II may not occur through a dtrect effect of renal nerves m microvascular reactivity. Rather, the effect of renal denervation on afferent artertolar responsiveness could be mediated by the associated reductton m MAP and thus a reduction m the microvascular compensation that occurs with chronically elevated arterial pressure Afferent arteriolar responsiveness to Ang II was not dlfferent between SH and DX rats Since renal denervatlon alone did not influence afferent arterlolar responsiveness to Ang II, basal sympathetic tone does not seem to be sufficient to enhance afferent arteriolar responsiveness to Ang II In contrast, the enhanced afferent arterlolar responsiveness to Ang II observed in ANG rats was prevented m ANGfDX rats These data suggest that sympathetic neurotransmission modulated by chronic Ang II mfusion contributes to the enhanced afferent artertolar responsiveness to Ang II Although mtrarenal norepmephrme content did not differ between SH and ANG rats, mtrarenal norepinephrme content IS not supposed to reflect dynamic neurotransmttter activity but only to indicate the effectiveness of renal denervation
In the present study, we also performed experiments to examme whether chronic Ang II mfuslon enhanced the calcium sensmvtty of arteriolar vascular smooth muscle, thereby enhancing mtcrovascular reactivity to a given stimulus. We examined afferent arteriolar reactivity to dtrect elevation of intracellular calcmm using the calcmm tonophore A23187, which acts as a freely mobile carrier to translocate tonic calcium from the extracellular medium to the cytosol via a receptor-independent mechanism 2s The present results indicate that A23187 caused a nearly identical vasoconstrtctton among all four groups and suggests that the calcium-induced contractile response is unaffected by chronic infusion of Ang II or renal denervatton Thus, the renal nerve-dependent mechanism by which chronic Ang II mfuston enhances afferent arteriolar responsiveness to acute Ang II does not involve modulation of the calcmm sensmvtty of afferent arteriolar smooth muscle cells.
Norepinephrine and Ang II are thought to utilize similar intracellular signal transduction pathways to elicit vasoconstriction Therefore, norepmephrme and Ang II could exert synergistic effects on vascular smooth muscle cells and luxtaglomerular cells.29JO A threshold dose of norept-nephrme enhanced the Ang II-induced vasoconstrlctlon or mhlbltlon of remn release through cw,-receptor-mediated actlvatlon of calcium channels.29J0 Since renal nerve stemulation elicits afferent arterlolar vasoconstriction in a frequency-dependent manner,14 modulation of neurotransmlsslon by chronic Ang II mfuslon could contmuously prime intracellular calcium moblhzatlon pathways at postsynaptic sites A recent study indicated that P-adrenerglc agonists and norepmephrme increased mRNA expression of the a,-subunit of L-type calcmm channels and increased the number of L-type calcium channels m myocytes 31 Therefore, m the present study, modulated neurotransmlsslon by chronic Ang II infusion could enhance the expression of functional calcium channels m afferent arterlolar smooth muscle cells and result m the enhanced responsiveness to acute admmlstratlon of Ang II Increased renal nerve actlvlty not only causes afferent and efferent arterlolar vasoconstrlctlon through activation of cwl-adrenerglc receptors but also stimulates postsynaptic ,!5adrenerglc receptors to Increase remn secretlon 32 It has been suggested that norepmephrme directly modulates Ang II receptor density High concentrations of noreplnephrme have been shown to Increase Ang II receptor number m neuronal cell cultures. 33 In addition, ,8-adrenerglc receptor actlvatlon stimulates and cY2-adrenerglc receptor activation mhlblts adenylate cyclase activity, thereby modulating intracellular CAMP levels 34 Since an mcrease m CAMP upregulates the Ang II receptor mRNA,35 the posslblhty remains that renal nerve transmlsslon may upregulate Ang II receptors through fi-receptor-mediated activation of CAMP.
Few studies have mvestlgated the effects of renal nerve act:vlty on the acute renal mlcrovascular responslveness to Ang II Exclusion of ,8,-adrenerglc mfluences or basal tonus of renal nerves did not affect Ang II-mediated afferent arterlolar vasoconstrlctlon.36,37 This observation 1s consistent with the current findings that no difference m afferent arterlolar reactivity to Ang II was noted between SH and DX rats However, the present data suggest that altered renal neurotransmlsslon modulated by chronic Ang II mfuslon does mfluence the acute responsiveness to Ang II Chronic Ang II mfuslon also enhanced afferent artenolar reactlvlty to norepmephrme, and this augmentation was not inhibited by renal denervatlon Therefore, renal nerve-independent enhancement of preglomerular reactlvlty seems to Involve a direct effect of chrome Ang II mfusion on afferent arterlolar smooth muscle cells In other studies, Ang II amplified the norepmephrme-induced vasoconstrlctlon through the actlvatlon of protein kmase C m isolated arteries of rabbits ?8 Chronic infusion of Ang II increases m&arena1 Ang II content, which may m turn potentlate afferent arterlolar smooth muscle cell contraction m response to norepmephrme Afferent arterlolar reactlvlty to norepmephrme was also enhanced by renal denervatlon alone Denervatlon 1s known to induce catecholamme supersensitivity medlated by adrenerglc receptor upregulation and an increase m receptor affinity for norepmephrme.39 Therefore, denervatlon-induced enhancement of afferent arterlolar reactlvlty to norepmephrme may be medlated by the modulation of specific adrenerglc receptors
In conclusion, m Ang II-infused hypertensive rats, MAP increases, and afferent arterlolar responsiveness to Ang II 1s enhanced. Renal denervatlon attenuates the development of hypertension and mhlblts the enhanced afferent arterlolar reactlvlty Enhanced afferent arterlolar reactivity cannot be explained on the basis of enhanced sensitivity of the vascular smooth muscle contractile apparatus for calcium 
